The rising cost of pharmaceutical expenditure in many European countries is of concern to governments required to make effective use of health care budgets. Taking a broad perspective that encompasses the institutional, political and supranational aspects of pharmaceutical regulation, this book examines the approaches used to manage pharmaceutical expenditure across Europe and what impact they have had on the efficiency, equity, quality and cost of pharmaceutical care. Regulating pharmaceuticals in Europe is an important book for students of health policy, regulation and management, and for health managers and policy-makers.